Zinfandel and Takeda team up for new Alzheimer's assay
This article was originally published in Clinica
Executive Summary
Japan's largest drugs company, Takeda Pharmaceutical, has gained exclusive worldwide rights to a new assay being developed by Zinfandel Pharma to assess Alzheimer's disease risk in healthy older patients.